WallStreetZenWallStreetZen

NASDAQ: GPCR
Structure Therapeutics Inc Stock Ownership - Who owns Structure Therapeutics?

Insider buying vs selling

Have Structure Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when GPCR insiders and whales buy or sell their stock.

GPCR Shareholders

What type of owners hold Structure Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Fil Ltd4.63%6,473,761$255.33MInsider
Fmr LLC3.82%5,345,338$210.82MInsider
Wellington Management Group LLP3.13%4,372,326$172.44MInstitution
Fmr LLC2.89%4,034,584$159.12MInstitution
Ramy Farid2.33%3,260,495$128.59MInsider
Raymond C. Stevens1.97%2,752,932$108.58MInsider
Jun Yoon1.92%2,677,719$105.61MInsider
Driehaus Capital Management LLC1.86%2,599,079$102.51MInstitution
Avoro Capital Advisors LLC1.67%2,333,333$92.03MInstitution
Federated Hermes Inc1.62%2,267,206$89.42MInstitution

1 of 3

GPCR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GPCR30.46%15.04%
FUSN71.20%28.80%
DNA58.22%13.98%Net SellingNet Selling
SNDX91.35%8.65%Net Buying
CPRX71.64%16.33%Net BuyingNet Buying

Structure Therapeutics Stock Ownership FAQ

Who owns Structure Therapeutics?

Structure Therapeutics (NASDAQ: GPCR) is owned by 30.46% institutional shareholders, 15.04% Structure Therapeutics insiders, and 54.50% retail investors. Fil Ltd is the largest individual Structure Therapeutics shareholder, owning 6.47M shares representing 4.63% of the company. Fil Ltd's Structure Therapeutics shares are currently valued at $254.55M.

If you're new to stock investing, here's how to buy Structure Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.